Literature DB >> 16202723

Randomized, double-blind, placebo-controlled trial of vaginal misoprostol for management of early pregnancy failures.

Margit S Lister1, Lynn E T Shaffer, Jeffrey G Bell, Kathleen Q Lutter, Karin H Moorma.   

Abstract

OBJECTIVE: To determine whether misoprostol medical management of early pregnancy failures is more effective than expectant management. STUDY
DESIGN: Patients diagnosed with early pregnancy failures, closed cervix, and minimal vaginal bleeding were randomized to 800 microg of misoprostol or placebo placed vaginally. Patients were evaluated by ultrasound imaging 24 hours and 48 hours after study drug administration, with repeat administration if 24-hour imaging showed a persistent gestational sac. Treatment success was defined as expulsion of uterine contents within 48 hours. Patient follow-up occurred 2 weeks after expulsion of uterine contents.
RESULTS: Treatment success occurred in 15 of 18 (83%) misoprostol patients and 2 of 16 (13%) placebo patients (P < .0001). Side effects were similar between groups except for vaginal bleeding, which was more common in the misoprostol group (P = .001). Patient satisfaction and pain perception were similar between groups.
CONCLUSION: Misoprostol appears to be highly effective for treating early pregnancy failures, with few side effects and high patient satisfaction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16202723     DOI: 10.1016/j.ajog.2005.05.010

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

1.  A Comparative Study to Evaluate the Efficacy of Vaginal vs Oral Prostaglandin E1 Analogue (Misoprostol) in Management of First Trimester Missed Abortion.

Authors:  Sheeba Marwah; Supriya Gupta; Neera Parothi Batra; Vidhu Bhasin; Veena Sarna; Nirlep Kaur
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Misoprostol for pre-term labor induction in the second trimester: Role of medical history and clinical parameters for prediction of time to delivery.

Authors:  Alexander di Liberto; Jan Endrikat; Sandra Frohn; Erich Solomayer; Kubilay Ertan
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-08-08

Review 3.  Medical treatments for incomplete miscarriage (less than 24 weeks).

Authors:  James P Neilson; Gillian Ml Gyte; Martha Hickey; Juan C Vazquez; Lixia Dou
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 4.  Medical treatments for incomplete miscarriage.

Authors:  Caron Kim; Sharmani Barnard; James P Neilson; Martha Hickey; Juan C Vazquez; Lixia Dou
Journal:  Cochrane Database Syst Rev       Date:  2017-01-31

5.  Medical treatment for early fetal death (less than 24 weeks).

Authors:  Marike Lemmers; Marianne Ac Verschoor; Bobae Veronica Kim; Martha Hickey; Juan C Vazquez; Ben Willem J Mol; James P Neilson
Journal:  Cochrane Database Syst Rev       Date:  2019-06-17

6.  Predictors of complete miscarriage after expectant management or misoprostol treatment of non-viable early pregnancy in women with vaginal bleeding.

Authors:  Anna Fernlund; Ligita Jokubkiene; Povilas Sladkevicius; Lil Valentin
Journal:  Arch Gynecol Obstet       Date:  2020-07-07       Impact factor: 2.344

7.  See-and-treat in-office hysteroscopy versus operative hysteroscopy for the treatment of retained products of conception: A retrospective study.

Authors:  Nili Raz; Emiliya Sigal; Fernando Gonzalez Arjona; Carmelo Calidona; Simone Garzon; Stefano Uccella; Antonio Simone Laganà; Sergio Haimovich
Journal:  J Obstet Gynaecol Res       Date:  2022-06-13       Impact factor: 1.697

8.  Methods for managing miscarriage: a network meta-analysis.

Authors:  Jay Ghosh; Argyro Papadopoulou; Adam J Devall; Hannah C Jeffery; Leanne E Beeson; Vivian Do; Malcolm J Price; Aurelio Tobias; Özge Tunçalp; Antonella Lavelanet; Ahmet Metin Gülmezoglu; Arri Coomarasamy; Ioannis D Gallos
Journal:  Cochrane Database Syst Rev       Date:  2021-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.